A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it do.
Pfizer Inc. (NYSE: PFE - Get Free Report)'s stock price traded up 1.5% during trading on Monday after UBS Group raised their price target on the stock from $25.00 to $27.00. UBS Group currently has a
Pfizer (PFE) reached $27.34 at the closing of the latest trading day, reflecting a +1.56% change compared to its last close.
Autoimmune diseases, oncology, and type 2 diabetes continue to spread around the world, but these stocks stay off investors' radars. Many of them consistently beat Street's consensus forecasts and off
The Dividend Harvesting Portfolio, focused on income and risk mitigation, achieved a 37.41% return on invested capital and $2,927.54 in projected annualized dividend income. Recent macro volatility—
Trellus Health PLC (AIM:TRLS), the digital chronic disease management platform, surged 39% to 0.28p after the company announced it had renewed its licensing agreement with Pfizer. Under the renewed de
Apollon Wealth Management LLC cut its holdings in shares of Pfizer Inc. (NYSE: PFE) by 15.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Carnegie Investment Counsel lifted its stake in Pfizer Inc. (NYSE: PFE) by 252.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 154,550 sha
Johnson & Johnson is one of the largest pharmaceutical stocks by market cap. Pfizer's dividend offers a hefty yield.
China's biotechs are faster and have lower costs, and its drug research threatens to soon overtake the West's
Pfizer boasts a juicy 6.4% dividend yield. Ongoing clinical progress could help rejuvenate its lineup.
ABBV edges out PFE as Skyrizi and Rinvoq fuel strong growth, offsetting Humira losses and positioning the drugmaker for sustained expansion.
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
BOCHK Asset Management Ltd raised its holdings in shares of Pfizer Inc. (NYSE: PFE) by 2,915.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2026 Annual Meeting of Shareholders on Thursday, April
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE